首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1397172

全球玻璃體手術器材市場：洞察、競爭格局、市場預測：2028 年

Vitrectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028

出版日期: 2023年12月18日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 1-3個工作天內

價格

簡介目錄圖表

2022 年全球玻璃體手術器械市場規模為 11.2 億美元，預計在 2023-2028 年預測期內複合年增長率為 7.12%。玻璃體手術器械的需求主要是由視網膜剝離和糖尿病視網膜病變等視網膜疾病的日益普及所推動的。此外，眼科領域的技術進步和新產品推出數量的增加是影響市場積極成長的其他主要因素。此外，預計 2023-2028 年預測期內，與視網膜撕裂和脫離相關的創傷病例數量的增加也將有助於玻璃體切割器械市場的整體成長。

根據IABP下屬的2020年視力喪失專家組提供的數據，2020年將有約100萬人因糖尿病視網膜病變失明，約300萬人出現中度至重度視力喪失。預計他患有殘疾。因此，各種視網膜疾病的日益普及預計將最終推動玻璃體手術器械市場的發展。

此外，國際糖尿病聯盟（IDF）2019年提供的數據估計，全球受糖尿病影響的總人數將從2030年的5.78億增加到2045年的7億。因此，糖尿病盛行率的增加也是導致糖尿病視網膜病變病例增加的重要因素，這也將在預測期內推動玻璃體手術器械市場的發展。

玻璃體切割器材市場的另一個主要驅動因素是越來越多地採用先進技術產品和新產品的推出。例如，2021 年 1 月，D.O.R.C 荷蘭眼科研究中心（國際）B.V. 獲得加拿大衛生部批准 TissueBlueTM。本產品用於玻璃體切除手術中內界膜（ILM）的染色。因此，越來越多的產品上市和批准、眼科領域不斷進步的技術進步正在推動玻璃體手術器械市場的成長。

然而，與玻璃體手術相關的併發症和與玻璃體手術器械相關的高成本是可能限制玻璃體切除器械市場成長的一些市場障礙。

本報告研究了全球玻璃體切割器械市場，並提供了市場概述，包括按產品、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。Masu。

Vitrectomy Devices Market By Product (Vitrectomy Systems And Vitrectomy Accessories), Application (Diabetic Retinopathy, Retinal Detachment, Vitreous Hemorrhage, And Others), End-User (Hospitals, Ophthalmology Clinics, And Ambulatory Surgical Centers), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of retinal disorders such as diabetic retinopathy and increase in new product launches and technical advancements in the domain of ophthalmology.

The global Vitrectomy Devices market was valued at USD 1.12 billion in 2022, growing at a CAGR of 7.12% during the forecast period from 2023 to 2028. The demand for Vitrectomy Devices is primarily being boosted by the increasing prevalence of retinal disorders such as retinal detachment, diabetic retinopathy, and others. Additionally, the increase in technological advancements and new product launches in the domain of ophthalmology are other key factors influencing the positive growth of the market. Further, the increasing number of trauma cases associated with retinal tear and detachment is also contributing to the overall growth of the Vitrectomy Devices market during the forecast period from 2023-2028.

Vitrectomy Devices Market Dynamics:

According to the data provided by Vision Loss Expert Group 2020, which is a part of IABP estimated that around 1 million people were suffering from blindness due to Diabetic Retinopathy in the year 2020, and around 3 million people had moderate to severe vision impairment, globally. Thus, the rising prevalence of various retinal disorders will eventually boost the market for Vitrectomy Devices.

Additionally, the data provided by the International Diabetes Federation (IDF) 2019, it was estimated that the total number of people suffering from diabetes will increase from 578 million in 2030 to 700 million in 2045, globally. Thus, the increasing prevalence of diabetes is also a significant factor contributing to the rise in the cases of diabetic retinopathy, which will also drive the Vitrectomy devices market during the forecast period.

Another key driver for the Vitrectomy devices market is the increase in the adoption of technological advancements products and new product launches. For Instance, in January 2021, D.O.R.C Dutch Ophthalmic Research Center (International) B.V. received approval of TissueBlueTM, from Health Canada. The product is used for staining of the internal limiting membrane (ILM), during vitrectomy surgeries. Therefore, the rising product launches, approvals, and increase in technological advancements in the domain of ophthalmology are propelling the growth of the vitrectomy devices market.

However, the complications associated with Vitrectomy procedures and the high cost associated with Vitrectomy Devices are some of the market barriers that may restrict the growth of the Vitrectomy Devices market.

Vitrectomy Devices Market Segment Analysis:

Vitrectomy Devices Market by Product (Vitrectomy Systems and Vitrectomy Accessories), Application (Diabetic Retinopathy, Retinal Detachment, Vitreous Hemorrhage, and Others), End-users (Hospitals, Ophthalmology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Vitrectomy Devices market, the Vitrectomy Systems category is expected to amass a significant revenue share in the year 2022. This can be attributed to the various advantages provided by the vitrectomy systems such as the presence of smart vitrectomy systems. Smart vitrectomy systems consisting of artificial intelligence, helps in providing real-time assistance to surgeons during the surgery in decision-making and provides more personalized and effective interventions. Additionally, continuous advancements in fluidic control systems and illumination technologies in vitrectomy devices are further contributing to better surgical environments. These systems ensure stable vitrectomy procedures, while improved illumination of the vitrectomy systems facilitates clearer visualization during the surgical procedure. Thus, the advantages provided by the Vitrectomy Systems are some of the key factors contributing to the growth of the segment.

Furthermore, as the demand for this segment grows, various products are launched in the market. For Instance, in March 2022, D.O.R.C Dutch Ophthalmic Research Center (International) B.V launched EVA NEXUS, an integrated system consisting of retina, cataract, and combined surgery capabilities.

Therefore, owing to the above-mentioned advantages and applications provided by Vitrectomy Systems, and the new product launches in this category is expected to register significant growth, thereby driving the growth of the overall Vitrectomy Devices market during the forecast period.

North America is expected to dominate the overall Vitrectomy Devices Market:

Among all the regions, North America is estimated to account for the largest share of the Vitrectomy Devices market in the year 2022. This can be attributed to the presence of a large patient pool suffering from various ophthalmological disorders. Additionally, easy availability of technologically advanced products, high awareness of diabetic retinopathy, easy availability of skilled ophthalmologists, and presence of major market players are among key factors influencing the growth of the market in North America.

According to a study published in JAMA Ophthalmology in the year 2021, "Prevalence of Diabetic Retinopathy in the US", it was estimated that 9.6 million people in the United States suffered from diabetic retinopathy in 2021. According to the same source, around 1.84 million people in the United States have vision threatening diabetic retinopathy (VTDR). Thus, the rising prevalence of various ophthalmological disorders will boost the market for Vitrectomy Devices in the United States, which in return will boost the overall Vitrectomy devices in North America.

According to the data provided by the Centers for Disease Control and Prevention (CDC) 2023, it was estimated that 29.7 million people, which accounts for 8.9% of the total population in the United States were diagnosed with Diabetes in the year 2021. Thus, the increasing prevalence of diabetes is a significant factor, which is contributing to the rise in the cases of diabetic retinopathy, which will eventually boost the market for Vitrectomy devices in the region.

Further, the presence of key market players and various key product launches and approvals in the region are some of the other factors that are influencing the positive growth of the market in the region. For Example, in April 2022, Carl Zeiss Meditec AG received FDA approval for the QUATERA 700 system.

Therefore, the factors mentioned above, and the presence of key market leaders with increasing product launches and product approvals in the region are some of the important factors which are thereby responsible for driving the overall market for Vitrectomy Devices in North America during the forecast period.

Vitrectomy Devices Market Key Players:

Some of the key market players operating in the Vitrectomy Devices market include: Alcon, Carl Zeiss Meditec AG, Lecia Microsystems, IRIDEX Corporation, Lumines Be Ltd., NIDEK CO., LTD., D.O.R.C Dutch Ophthalmic Research Center (International) B.V., Geuder AG, Optos, Hoya Surgical Optics, BVI, and Johnson & Johnson, Inc.

Recent Developmental Activities in the Vitrectomy Devices Market:

In July 2021, D.O.R.C Dutch Ophthalmic Research Center (International) B.V. launched its EVA EquiPhaco angled needles, equipped with enhanced chamber stability and ultrasonic efficiency.
In January 2019, Hoya Surgical Optics acquired Mid Labs and Fritz Ruck. The main objective of the acquisition is to help Hoya Surgical Optics to expand its product offerings.

Key Takeaways from the Vitrectomy Devices Market Report Study:

Market size analysis for current Vitrectomy Devices market size (2022), and market forecast for 5 years (2023-2028)
Top key product/and technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global Vitrectomy Devices market.
Various opportunities available for the other competitors in the Vitrectomy Devices market space.
What are the top-performing segments in 2022? How these segments will perform in 2028?
Which are the top-performing regions and countries in the current Vitrectomy Devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Vitrectomy Devices market growth in the coming future?

Target Audience who can be benefited from this Vitrectomy Devices Market Report Study:

Vitrectomy Devices product providers
Research organizations and consulting companies
Vitrectomy Devices -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Vitrectomy Devices
Various End-users who want to know more about the Vitrectomy Devices market and the latest technological developments in the Vitrectomy Devices market

Frequently Asked Questions for the Vitrectomy Devices Market:

1. What is meant by Vitrectomy Devices?

Vitrectomy Devices are surgical instruments used during vitrectomy. Vitrectomy refers to a surgical technique to remove or replace the vitreous humor (gel-like substance) present inside the eye. These devices typically include vitrectomy systems and other accessories that aid in the removal of vitreous tissue.

2. What is the market for global Vitrectomy Devices?

The global Vitrectomy Devices market was valued at USD 1.12 billion in 2022, growing at a CAGR of 7.12% during the forecast period from 2023 to 2028.

3. What are the drivers for the global Vitrectomy Devices market?

The Vitrectomy Devices market is slated to witness prosperity owing to factors such as the increasing prevalence of retinal disorders such as Diabetic Retinopathy and other factors causing the disease. Additionally, new product launches and technical advancements in the domain of ophthalmology will further propel the growth of the market. Further, an increase in several trauma cases associated with retinal tear and detachment will also result in appreciable revenue growth in the Vitrectomy Devices market during the forecast period (2023-2028).

4. Who are the key players operating in the global Vitrectomy Devices market?

Some of the key market players operating in the Vitrectomy Devices market include Alcon, Carl Zeiss Meditec AG, Lecia Microsystems, IRIDEX Corporation, Lumines Be Ltd., NIDEK CO., LTD., D.O.R.C Dutch Ophthalmic Research Center (International) B.V, Geuder AG, Optos, Hoya Surgical Optics, BVI, and Johnson & Johnson, Inc.

5. Which region has the highest share in the global Vitrectomy Devices market?

North America is expected to dominate the overall Vitrectomy Devices Market during the forecast period, 2023 to 2028. Due to the presence of a large patient pool suffering from ophthalmological disorders. Additionally, the easy availability of technologically advanced products in the region is another contributing factor to the growth of the Vitrectomy Devices market in North America. Further, the region has a very potent market for product development and launches, and the presence of a high concentration of market players in the region will also help in boosting the market for vitrectomy devices in North America.

1. Vitrectomy Devices Market Report Introduction

2. Vitrectomy Devices Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Vitrectomy Devices Market Key Factors Analysis

4.1. Vitrectomy Devices Market Drivers
- 4.1.1. Increasing prevalence of Retinal Disorders such as Diabetic Retinopathy and other factors causing the disease
- 4.1.2. New product launches and technical advancements in the domain of ophthalmology
- 4.1.3. Increase in the number of Trauma cases associated with retinal tear and detachment
4.2. Vitrectomy Devices Market Restraints and Challenges
- 4.2.1. Complications associated with Vitrectomy
- 4.2.2. High cost associated with Vitrectomy Devices
4.3. Vitrectomy Devices Market Opportunities
- 4.3.1. Potential growth opportunities in the emerging markets

5. Vitrectomy Devices Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. Vitrectomy Devices Market Layout

6.1. By Product
- 6.1.1. Vitrectomy Systems
- 6.1.2. Vitrectomy Accessories
6.2. By Application
- 6.2.1. Diabetic Retinopathy
- 6.2.2. Retinal Detachment
- 6.2.3. Vitreous Hemorrhage
- 6.2.4. Other Applications
6.3. By End-user
- 6.3.1. Hospitals
- 6.3.2. Ophthalmology Clinics
- 6.3.3. Ambulatory Surgical Centers
6.4. By Geography
- 6.4.1. North America
  - 6.4.1.1. United States Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.1.2. Canada Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.1.3. Mexico Vitrectomy Devices Market Size in USD million (2020-2028)
- 6.4.2. Europe
  - 6.4.2.1. France Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.2.2. Germany Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.2.3. United Kingdom Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.2.4. Italy Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.2.5. Spain Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.2.6. Rest of Europe Vitrectomy Devices Market Size in USD million (2020-2028)
- 6.4.3. Asia-Pacific
  - 6.4.3.1. China Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.3.2. Japan Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.3.3. India Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.3.4. Australia Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.3.5. South Korea Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.3.6. Rest of Asia-Pacific Vitrectomy Devices Market Size in USD million (2020-2028)
- 6.4.4. Rest of the World (RoW)
  - 6.4.4.1. Middle East Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.4.2. Africa Vitrectomy Devices Market Size in USD million (2020-2028)
  - 6.4.4.3. South America Vitrectomy Devices Market Size in USD million (2020-2028)

7. Vitrectomy Devices Market Company and Product Profiles

7.1. Alcon
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2. Carl Zeiss Meditec AG
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3. Leica Microsystems
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4. IRIDEX Corporation
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5. Lumenis Be Ltd.
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6. NIDEK CO., LTD.
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7. D.O.R.C Dutch Ophthalmic Research Center (International) B.V
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8. Geuder AG
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9. Optos
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10. Hoya Surgical Optics
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11. BVI
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12. Johnson & Johnson, Inc.
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy